FDA Drug Recalls

Recalls / Class II

Class IID-1865-2019

Product

Allergy Relief (Fexofenadine Hydrochrloride) Tablets USP, 180 mg, packaged in a) 15-count cartons (NDC 60000-409-53); b) 30-count cartons (NDC 60000-409-30); c) 45-count bonus cartons (NDC 60000-409-48); d) 45-count cartons (NDC 60000-409-45); CAREone, Distributed by: Foodhold U.S.A., LLC, Landover, MD 20785.

Affected lot / code info
Lot #s: a) 067180025D1, Exp 07/21; b) 067180025B1, Exp 07/21; c) 067180025A1, Exp 07/21; d) 067180025C1, Exp 07/21

Why it was recalled

Failed Impurities/Degradation Specifications

Recalling firm

Firm
Aurolife Pharma, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2400 US Highway 130, N/A, Dayton, New Jersey 08810-1519

Distribution

Quantity
a) 9662 cartons; b) 7382 cartons; c) 5184 cartons; d) 9842 cartons
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2019-08-23
FDA classified
2019-09-17
Posted by FDA
2019-09-25
Terminated
2022-08-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1865-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls